Search Within

Nour Abuhadra

Formats
  1. Meeting Abstract (13)
  2. Journal Article (7)
  3. Review (3)
  4. Miscellaneous (2)
Groups
  1. Surgery (12)
  2. Epidemiology and Biostatistics (11)
  3. Breast Medicine Service (10)
  4. Department of Medicine (10)
  5. Solid Tumor Oncology Division (10)
  6. Graduate Medical Education (9)

More Groups

People
  1. Stephanie Downs-Canner (10)
  2. George Plitas (7)
  3. Monica Morrow (7)
  4. Srinivasa Sevilimedu Veeravalli (7)
  5. Giacomo Montagna (6)
  6. Natalia Polidorio Machado (5)

More People

Years
  1. 2025 (4)
  2. 2024 (10)
  3. 2023 (7)
  4. 2022 (4)
Publications
  1. Annals of Surgical Oncology (6)
  2. Journal of Clinical Oncology (6)
  3. Annals of Oncology (2)
  4. Gynecologic Oncology (2)
  5. Archives of Dermatological Research (1)
  6. Cancer Treatment Reviews (1)

More Publications

Publishers
  1. Springer (7)
  2. American Society of Clinical Oncology (6)
  3. Elsevier Inc. (4)
  4. Oxford University Press (3)
  5. Elsevier Science, Inc. (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Emiltatug ledadotin (Emi-Le): A B7-H4-directed dolasynthen antibody-drug conjugate (ADC) being investigated in phase 1 dose expansion in patients with triple negative breast cancer who received at least one prior topoisomarase-1 inhibitor ADC
    Meeting Abstract

    Han, H. S.; Kalinsky, K.; Abuhadra, N.; Giordano, A.; Starks, D.; Wulf, G. M.; McAndrew, N. P.; O'Shaughnessy, J.; Spira, A. I.; Chan, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Timing of neoadjuvant pembrolizumab infusion and pathologic complete response among patients with triple-negative breast cancer receiving the KEYNOTE-522 regimen
    Meeting Abstract

    Shen, S.; Myers, S.; Polidorio, N.; Bromberg, M.; Chen, Y.; Tan, R.; Mai, N.; Abuhadra, N.; Traina, T. A.; Downs-Canner, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Predictors of pathologic complete response with neoadjuvant chemo-immunotherapy in early-stage triple-negative breast cancer
    Journal Article

    Perry, L. M.; Sevilimedu, V.; Polidorio, N.; Abuhadra, N.; Morrow, M.; Plitas, G.; Downs-Canner, S.
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Predictors of pathologic complete response with neoadjuvant chemo-immunotherapy in early-stage triple-negative breast cancer
    Miscellaneous

    Perry, L. M.; Sevilimedu, V.; Polidorio, N.; Abuhadra, N.; Morrow, M.; Plitas, G.; Downs-Canner, S.
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • XMT-1660: A phase I, first-in-human trial of a B7-H4-directed dolasynthen antibody-drug conjugate in ovarian, endometrial, and breast cancers
    Meeting Abstract

    Burger, R.; Hamilton, E.; Adams, S.; Han, H.; Spira, A.; Giordano, A.; Chaudhry, A.; Parajuli, R.; Wang, J.; Weise, A.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Predictors of immediate and delayed cutaneous hypersensitivity reactions to paclitaxel
    Journal Article

    Trager, M. H.; Kuo, A. M.; Dusza, S. W.; Park, V.; Geskin, L.; Guyer, A.; Abuhadra, N.; Gucalp, A.; Lacouture, M. E.
    Archives of Dermatological Research (2024)

    Fulltext@MSK | Save
  • Predictors of immediate and delayed cutaneous hypersensitivity reactions to paclitaxel
    Meeting Abstract

    Trager, M. H.; Kuo, A. M. S.; Dusza, S. W.; Park, V.; Geskin, L. J.; Guyer, A.; Abuhadra, N.; Gucalp, A.; Lacouture, M. E.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review
    Journal Article

    Remilah, A. A.; Krayim, B.; Amir, E.; Tibau, A.; Robson, M. E.; Abuhadra, N.; Chen, Y.; Shepshelovich, D.; Goldvaser, H.
    Critical Reviews in Oncology/Hematology (2024)

    Fulltext@MSK | Save
  • Impact of neoadjuvant chemoimmunotherapy on surgical outcomes and time to radiation in triple-negative breast cancer
    Journal Article

    Myers, S. P.; Sevilimedu, V.; Jones, V. M.; Abuhadra, N.; Montagna, G.; Plitas, G.; Morrow, M.; Downs-Canner, S. M.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Impact of neoadjuvant chemoimmunotherapy on surgical outcomes and time to radiation in triple-negative breast cancer
    Miscellaneous

    Myers, S. P.; Sevilimedu, V.; Jones, V. M.; Abuhadra, N.; Montagna, G.; Plitas, G.; Morrow, M.; Downs-Canner, S. M.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save